Analyst Ratings for Relay Therapeutics (RLAY)
RLAY Rating Summary
RLAY Price Target Summary
- Highest: $15.00 (Citizens)
- Lowest: $14.00 (Oppenheimer)
- Average: $14.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.75 (+49.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$14.75 (+49.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/26/2026 | Oppenheimer | Matt Biegler | Upgrade | Outperform (Perform) |
14.00 (N/A) |
7.43 (9.89) |
33.11% | Details |
| 12/12/2025 | Wells Fargo » Updated 2/27/2026 |
Eva Fortea Verdejo | Upgrade | Overweight (Equal Weight) |
15.00 (13.00) |
7.79 (9.89) |
26.96% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
